|
Name |
4-Hydroxy-3-methoxyphenethylene glycol triTMS
|
| Molecular Formula | C18H36O4Si3 | |
| IUPAC Name* |
[4-[1,2-bis(trimethylsilyloxy)ethyl]-2-methoxyphenoxy]-trimethylsilane
|
|
| SMILES |
COC1=C(C=CC(=C1)C(CO[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C
|
|
| InChI |
InChI=1S/C18H36O4Si3/c1-19-17-13-15(11-12-16(17)21-24(5,6)7)18(22-25(8,9)10)14-20-23(2,3)4/h11-13,18H,14H2,1-10H3
|
|
| InChIKey |
AAFYLSSHQRPLSR-UHFFFAOYSA-N
|
|
| Synonyms |
4-Hydroxy-3-methoxyphenethylene glycol triTMS; (4-Hydroxy-3-methoxyphenyl)ethylene glycol tris(trimethylsilyl) ether; 4-Hydroxy-3-methoxyphenylglycol, 3TMS derivative; 1,2-Ethanediol, 4-hydroxy-3-methoxyphenyl, tris-TMS; [[1-[3-Methoxy-4-[(trimethylsilyl)oxy]phenyl]-1,2-ethanediyl]bis(oxy)]bis(trimethylsilane); 4-(3-Methoxy-4-[(trimethylsilyl)oxy]phenyl)-2,2,7,7-tetramethyl-3,6-dioxa-2,7-disilaoctane #; 68595-81-3
|
|
| CAS | NA | |
| PubChem CID | 530366 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 400.7 | ALogp: | 5.7 |
| HBD: | 0 | HBA: | 4 |
| Rotatable Bonds: | 9 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 36.9 | Aromatic Rings: | 1 |
| Heavy Atoms: | 25 | QED Weighted: | 0.49 |
| Caco-2 Permeability: | -5.274 | MDCK Permeability: | 0.00001420 |
| Pgp-inhibitor: | 0.108 | Pgp-substrate: | 0.017 |
| Human Intestinal Absorption (HIA): | 0.5 | 20% Bioavailability (F20%): | 0.082 |
| 30% Bioavailability (F30%): | 0.006 |
| Blood-Brain-Barrier Penetration (BBB): | 0.002 | Plasma Protein Binding (PPB): | 98.66% |
| Volume Distribution (VD): | 3.065 | Fu: | 13.26% |
| CYP1A2-inhibitor: | 0.562 | CYP1A2-substrate: | 0.986 |
| CYP2C19-inhibitor: | 0.228 | CYP2C19-substrate: | 0.939 |
| CYP2C9-inhibitor: | 0.294 | CYP2C9-substrate: | 0.891 |
| CYP2D6-inhibitor: | 0.062 | CYP2D6-substrate: | 0.88 |
| CYP3A4-inhibitor: | 0.117 | CYP3A4-substrate: | 0.661 |
| Clearance (CL): | 2.787 | Half-life (T1/2): | 0.238 |
| hERG Blockers: | 0.237 | Human Hepatotoxicity (H-HT): | 0.018 |
| Drug-inuced Liver Injury (DILI): | 0.03 | AMES Toxicity: | 0.041 |
| Rat Oral Acute Toxicity: | 0 | Maximum Recommended Daily Dose: | 0.076 |
| Skin Sensitization: | 0.941 | Carcinogencity: | 0.043 |
| Eye Corrosion: | 0.996 | Eye Irritation: | 0.95 |
| Respiratory Toxicity: | 0.604 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001149 | ![]() |
0.476 | D01JFT | ![]() |
0.250 | ||
| ENC001399 | ![]() |
0.476 | D09GYT | ![]() |
0.235 | ||
| ENC001123 | ![]() |
0.476 | D0R0FE | ![]() |
0.228 | ||
| ENC001122 | ![]() |
0.434 | D0Q9ON | ![]() |
0.226 | ||
| ENC000530 | ![]() |
0.333 | D01SAT | ![]() |
0.225 | ||
| ENC001404 | ![]() |
0.326 | D0NJ3V | ![]() |
0.225 | ||
| ENC001401 | ![]() |
0.324 | D0VU8Q | ![]() |
0.216 | ||
| ENC001363 | ![]() |
0.301 | D02XJY | ![]() |
0.213 | ||
| ENC001270 | ![]() |
0.294 | D01FFA | ![]() |
0.209 | ||
| ENC001373 | ![]() |
0.284 | D02LZB | ![]() |
0.207 | ||